Outcomes of patients with intermediate‐risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531.

MLA

Voeller, Julie, et al. “Outcomes of Patients with Intermediate‐risk Neuroblastoma Presenting with Motor Deficits Relating to Intraspinal Tumor Extension: A Report from the Children’s Oncology Group Study ANBL0531.” Pediatric Blood & Cancer, vol. 72, no. 1, Jan. 2025, pp. 1–10. EBSCOhost, https://doi.org/10.1002/pbc.31407.

APA

Voeller, J., Katzenstein, H. M., Naranjo, A., Tenney, S. C., Chen, L., London, W. B., Handler, M. H., Schmidt, M. L., Shimada, H., Hogarty, M. D., Gastier, F. J., Park, J. R., Cohn, S. L., Maris, J. M., Bagatell, R., & Twist, C. J. (2025). Outcomes of patients with intermediate‐risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children’s Oncology Group study ANBL0531. Pediatric Blood & Cancer, 72(1), 1–10. https://doi.org/10.1002/pbc.31407

Chicago

Voeller, Julie, Howard M. Katzenstein, Arlene Naranjo, Sheena C. Tenney, Lulu Chen, Wendy B. London, Michael H. Handler, et al. 2025. “Outcomes of Patients with Intermediate‐risk Neuroblastoma Presenting with Motor Deficits Relating to Intraspinal Tumor Extension: A Report from the Children’s Oncology Group Study ANBL0531.” Pediatric Blood & Cancer 72 (1): 1–10. doi:10.1002/pbc.31407.